Cervical length changes during preterm cervical ripening: effects of 17-α-hydroxyprogesterone caproate

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 5, 2007, Pages 453.e1-453.e4

  Facchinetti, Fabio ^a   Paganelli, Simone ^a   Comitini, Giuseppina ^b   Dante, Giulia ^a   Volpe, Annibale ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

17 hydroxyprogesterone caproate; cervical length; preterm delivery; preterm labor; transvaginal ultrasound scan

Indexed keywords

ATOSIBAN; BETAMETHASONE; HYDROXYPROGESTERONE CAPROATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FETUS LUNG MATURITY; HUMAN; MAJOR CLINICAL STUDY; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOCOLYSIS; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX RIPENING;

EID: 34247214542     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.09.009     Document Type: Article

References (25)

1. Meis P.J. 17 Hydroxyprogesterone for the prevention of preterm delivery. Obstet Gynecol 105 (2005) 1128-1135
2. Yemini M Borenstein R., Dreazen E., et al. Prevention of premature labor by 17-α-hydroxyprogesterone caproate. Am J Obstet Gynecol 151 (1975) 574-577
3. Johnson J.W., Austin K.L., Jones G.S., Davis G.H., and King T.M. Efficacy of 17-α-hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med 293 (1975) 675-680
4. Meis P.J., Klebanoff M., Thom E., Dombrowski M.P., Sibai B., and Moawad A.H. Prevention of recurrent preterm delivery by alpha-hydroxyprogesterone caproate. N Engl J Med 348 (2003) 2379-2385
5. Mesiano S. Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Invest 11 (2004) 193-202
6. Elovitz A., and Mrinalini C. Can medroxyprogesterone acetate alter toll-like receptor expression in a mouse model of intrauterine inflammation?. Am J Obstet Gynecol 193 (2005) 1149-1155
7. Amory J., Lawler R., and Shields L. Hydroxyprogesterone caproate and progesterone increase tumor necrosis factor-alpha production in lipopolysaccharide stimulated whole blood from non pregnant women. J Perinat Med 33 (2005) 506-509
8. Gomez R., Galasso M., Romero R., et al. Ultrasonographic evaluation of the uterine cervix is better than cervical digital examination as a predictor of the likelihood of premature delivery in patients with premature labor and intact membranes. Am J Obstet Gynecol 171 (1994) 956-964
9. Iams J.D., Paraskos J., Landon M.B., Teteris J.N., and Johnson F.F. Cervical sonography in preterm labor. Obstet Gynecol 84 (1994) 40-46
10. Okitsu O., Mimuraa T., Nakayama T., and Aono T. Early prediction of preterm delivery by transvaginal ultrasonography. Ultrasound Obstet Gynecol 2 (1992) 402-409
11. Berghella V., Tolosa J.E., Kuhlman K., Weiner S., Bolognese R.J., and Wapner R.J. Cervical ultrasonography compared with manual examination as a predictor of preterm delivery. Am J Obstet Gynecol 1777 (1997) 723-730
12. Goldbenberg R.L., Iams J.D., Mercer B.M., et al. What we have learned about predictors of preterm labor. Semin Perinatol 27 (2003) 185-193
13. Berghella V., Ness A., Bega G., and Berghella M. Cervical sonography in women with symptoms of preterm labor. Obstet Gynecol Clin North Am 32 (2005) 383-396
14. Papatsonis D., Flenady V., Cole S., and Liley H. Oxytocin receptor antagonists for inhibiting preterm labor [review]. Cochrane Database Syst Rev 20 (2005) CD004452
15. Rozenberg P., Rudant J., Chevret S., Boulogne A., and Ville Y. Repeat measurement of cervical length after successful tocolysis. Obstet Gynecol 104 (2004) 995-999
16. Liggins G.C. Ripening of the cervix. Semin Perinatol 2 (1978) 261-271
17. Lockwood C.J., Ghidini A., Wein R., Lapinsky R., Casal D., and Berkowitz R.L. Increased interleukin-6 concentrations in cervical secretions are associated with preterm delivery. Am J Obstet Gynecol 171 (1994) 1097-1102
18. Facchinetti F., Venturini P., Blasi I., and Giannella L. Changes in cervical competence in preterm labour. BJOG 112 suppl (2005) 23-27
19. Piccinini F., Fano R.A., Volpe A., and Facchinetti F. Ripening of the cervix with sodium nitroprusside in non pregnant women. J Soc Gynecol Investig 10 (2003) 438-442
20. Fuchs F., and Stakemann G. Treatment of threatened premature labor with large doses of progesterone. Am J Obstet Gynecol 79 (1960) 172-176
21. Erny R., Pigne A., Prouvost C., et al. The effects of oral administration of progesterone for premature labor. Am J Obstet Gynecol 154 (1986) 525-529
22. Noblot G., Audra P., Dargent D., et al. The use of micronized progesterone in the treatment of menace of preterm delivery. Eur J Obstet Gynecol Reprod Biol 40 (1991) 203-209
23. Brenner W.E., and Hendricks C.H. Effect of medroxyprogesterone acetate upon the duration and characteristics of human gestation and labor. Am J Obstet Gynecol 83 (1962) 1094-1098
24. Kauppila A., Hartikainen-Sorri A.L., Janne O., Tuimala R., and Jarvinen P.A. Suppression of threatened premature labor by administration of cortisol and 17-alpha-hydroxyprogesterone caproate: a comparison with ritodrine. Am J Obstet Gynecol 138 (1980) 404-408
25. Szekeres-Bartho J., Barakonyi A., Par G., Polgar B., Palcovics T., and Szereday L. Progesterone as an immunomodulatory molecule. Int Immunopharmacol 1 (2001) 1037-1048